Terms: = Colorectal cancer AND FOXO3, FKHRL1, 2309, ENSG00000118689, MGC31925, MGC12739, FOXO2, FOXO3A, O43524, AF6q21, FKHRL1P2, DKFZp781A0677
121 results:
1. CDK12 inhibition upregulates ATG7 triggering autophagy via AKT/foxo3 pathway and enhances anti-PD-1 efficacy in colorectal cancer.
Wu Z; Zhang W; Chen L; Wang T; Wang X; Shi H; Zhang L; Zhong M; Shi X; Mao X; Chen H; Li Q
Pharmacol Res; 2024 Mar; 201():107097. PubMed ID: 38354870
[TBL] [Abstract] [Full Text] [Related]
2. foxo3: at the crossroads of metabolic, inflammatory, and tumorigenic remodeling in the colon.
Snarski P; Ghimire J; Savkovic SD
Am J Physiol Gastrointest Liver Physiol; 2024 Mar; 326(3):G247-G251. PubMed ID: 38193202
[TBL] [Abstract] [Full Text] [Related]
3. 5-methoxytryptophan induced apoptosis and PI3K/Akt/foxo3a phosphorylation in colorectal cancer.
Zhao TL; Qi Y; Wang YF; Wang Y; Liang H; Pu YB
World J Gastroenterol; 2023 Dec; 29(47):6148-6160. PubMed ID: 38186686
[TBL] [Abstract] [Full Text] [Related]
4. Pro-carcinogenic actions of miR-155/foxo3a in colorectal cancer development.
Wang D; Geng W; Han L; Song R; Qu Q; Chen X; Luo X
Cell Mol Biol (Noisy-le-grand); 2023 Oct; 69(10):160-165. PubMed ID: 37953568
[TBL] [Abstract] [Full Text] [Related]
5. Genetic Profile of foxo3 Single-Nucleotide Polymorphism in colorectal cancer Patients.
Uroog L; Rahmani AH; Alsahli MA; Almatroodi SA; Wani RA; Rizvi MMA
Oncology; 2024; 102(4):299-309. PubMed ID: 37857267
[TBL] [Abstract] [Full Text] [Related]
6. 3-Bromopyruvate overcomes cetuximab resistance in human colorectal cancer cells by inducing autophagy-dependent ferroptosis.
Mu M; Zhang Q; Zhao C; Li X; Chen Z; Sun X; Yu J
Cancer Gene Ther; 2023 Oct; 30(10):1414-1425. PubMed ID: 37558749
[TBL] [Abstract] [Full Text] [Related]
7. Molecular dissection of anti-colon cancer activity of NARI-29: special focus on H
Np S; Rajdev B; Jain S; Gangasani JK; Vaidya JR; Naidu V
Free Radic Res; 2023 Apr; 57(4):308-324. PubMed ID: 37523668
[TBL] [Abstract] [Full Text] [Related]
8. foxo3 Deficiency in Neutrophils Drives Colonic Inflammation and Tumorigenesis.
Ghimire J; Iftikhar R; Penrose HM; Snarski P; Ruiz E; Savkovic SD
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298680
[TBL] [Abstract] [Full Text] [Related]
9. Ribosomal protein RPL5 regulates colon cancer cell proliferation and migration through MAPK/ERK signaling pathway.
Zhang H; Liu J; Dang Q; Wang X; Chen J; Lin X; Yang N; Du J; Shi H; Liu Y; Han J
BMC Mol Cell Biol; 2022 Nov; 23(1):48. PubMed ID: 36384455
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic Assessment of Oxidative Stress-Related Genes in colorectal cancer and New Insights into Tumor Immunity.
Chen Z; Mei K; Xiao Y; Xiong Y; Long W; Wang Q; Zhong J; Di D; Ge Y; Luo Y; Li Z; Huang Y; Gu R; Wang B
Oxid Med Cell Longev; 2022; 2022():2518340. PubMed ID: 36299603
[TBL] [Abstract] [Full Text] [Related]
11. Downregulation of TEX11 promotes S-Phase progression and proliferation in colorectal cancer cells through the foxo3a/COP1/c-Jun/p21 axis.
Zhang X; Hu F; Zhu B; Jiao X; Li Y; Wu S; Ren G; Li J; Xie Q; Pan Y; Li H; Zhao L
Oncogene; 2022 Nov; 41(47):5133-5145. PubMed ID: 36258021
[TBL] [Abstract] [Full Text] [Related]
12. ANGPTL1, foxo3a-Sox2, and colorectal cancer metastasis.
Jiang K; Chen H; Ding K
Clin Sci (Lond); 2022 Sep; 136(18):1367-1370. PubMed ID: 36156125
[TBL] [Abstract] [Full Text] [Related]
13. Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of foxo3-FOXM1 axis.
Ghosh S; Singh R; Vanwinkle ZM; Guo H; Vemula PK; Goel A; Haribabu B; Jala VR
Theranostics; 2022; 12(12):5574-5595. PubMed ID: 35910798
[TBL] [Abstract] [Full Text] [Related]
14. JIB-04, a Pan-Inhibitor of Histone Demethylases, Targets Histone-Lysine-Demethylase-Dependent AKT Pathway, Leading to Cell Cycle Arrest and Inhibition of cancer Stem-Like Cell Properties in Hepatocellular Carcinoma Cells.
Lee J; Kim JS; Cho HI; Jo SR; Jang YK
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887001
[TBL] [Abstract] [Full Text] [Related]
15. Oleanolic acid induces HCT116 colon cancer cell death through the p38/foxo3a/Sirt6 pathway.
Potočnjak I; Šimić L; Vukelić I; Batičić L; Domitrović R
Chem Biol Interact; 2022 Aug; 363():110010. PubMed ID: 35690101
[TBL] [Abstract] [Full Text] [Related]
16. PIK3CA mutations-mediated downregulation of circLHFPL2 inhibits colorectal cancer progression via upregulating PTEN.
Chong X; Chen J; Zheng N; Zhou Z; Hai Y; Chen S; Zhang Y; Yu Q; Yu S; Chen Z; Bao W; Quan M; Chen ZS; Zhan Y; Gao Y
Mol Cancer; 2022 May; 21(1):118. PubMed ID: 35619132
[TBL] [Abstract] [Full Text] [Related]
17. ANGPTL1 attenuates cancer migration, invasion, and stemness through regulating foxo3a-mediated SOX2 expression in colorectal cancer.
Chang TY; Lan KC; Chiu CY; Sheu ML; Liu SH
Clin Sci (Lond); 2022 May; 136(9):657-673. PubMed ID: 35475476
[TBL] [Abstract] [Full Text] [Related]
18. Avenanthramide C induces cellular senescence in colorectal cancer cells via suppressing β-catenin-mediated the transcription of miR-183/96/182 cluster.
Fu R; Dou Z; Li N; Zhang J; Li Z; Yang P
Biochem Pharmacol; 2022 May; 199():115021. PubMed ID: 35358479
[TBL] [Abstract] [Full Text] [Related]
19. OSI-027 inhibits the tumorigenesis of colon cancer through mediation of c-Myc/foxo3a/PUMA axis.
Lou J; Lv JX; Zhang YP; Liu ZJ
Cell Biol Int; 2022 Aug; 46(8):1204-1214. PubMed ID: 35293663
[TBL] [Abstract] [Full Text] [Related]
20. TSPYL2 reduced gefitinib resistance and DNA damage repair via suppressing SIRT1-mediated foxo3 deacetylation.
Liu Z; Li C; Yu C; Chen Z; Zhao C; Ye L
Future Med Chem; 2022 Mar; 14(6):407-419. PubMed ID: 35192400
[No Abstract] [Full Text] [Related]
[Next]
